SECTION I · THE BRIEF
Brief #01227Updated 12 AUG 2026REMOTEGreenhouseMEDICAL ORGANIZATIONS
Employbl Company Profile

Director, Safety Management, Japan

Revolution Medicines, Inc. operates as an oncology company. The Company discovers novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways. Revolution Medicines serves…

Location
Remote
Company size
700–700
Posted
6d ago
Via
Greenhouse
Section II · Premium ProfileMembers only
  • 01Comp band & equity packageLocked
  • 02Seniority & experience requirementsLocked
  • 03Interview process & rubricLocked
  • 04Hiring manager & team contextLocked
  • 05Growth trajectory in this roleLocked
  • 06Offer & decision timelineLocked

7-day free trial · $25/mo · cancel anytime

REVOLUTION Medicines logo

Director, Safety Management, Japan · REVOLUTION Medicines

View company profile
Job title
Director, Safety Management, Japan
Job location
Remote (Japan)
Job description

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

Revolution Medicines is seeking a Director level professional to lead safety management activities for its Japan entity and to serve as the Safety Management Manager (Anseki) under Japanese regulations.

The Safety Management Lead is responsible for establishing and overseeing safety management activities for the Japan entity and supporting the establishment and maintenance of the Japan Marketing Authorization Holder (MAH). In this role, the Safety Management Lead is also responsible for ensuring that all relevant pharmacovigilance requirements for Revolution Medicines are fulfilled. 

The role operates as part of the legally required three-role framework, working in close collaboration with Marketing Supervisor General (Soseki) and Quality Assurance Manager (Hinseki) to ensure effective governance across safety, quality, and regulatory domains.

Key Responsibilities:  

  • Accountable for maintaining compliance with PMDA, PV Agreements, and the Japanese Risk Management Plan (J-RMP).

  • Lead the design, implementation, and maintenance of the safety management system in accordance with Japanese GVP/GPSP regulations, appropriate for a pre-commercial and early-stage organization.

  • Serve as the designated Safety Management Manager (Anseki) and primary safety contact for Japanese health authorities.

  • Establish safety-related SOPs, procedures, and governance frameworks covering safety information collection, evaluation, reporting, and escalation.

  • Provide oversight of safety activities conducted by global teams and/or external service providers, ensuring compliance with Japanese requirements including development of the J-RMP, conducting Early Post-marketing Phase Vigilance (EPPV), analysis of safety information, monitoring of benefit-risk balance, and local literature review in support of signal detection activities.

  • Evaluate safety information derived from clinical development, medical activities, and external sources, and contribute to benefit-risk assessments.

  • Collaborate with Medical Affairs and Clinical Development functions to ensure appropriate handling and escalation of safety information.

  • Work closely with Marketing Supervisor General (Soseki) and Quality Assurance Manager (Hinseki) to ensure timely information sharing, escalation, and decision-making within the three-role framework.

  • Support Soseki decision-making by providing safety input during MAH establishment and early operational phases.

  • Act as the primary safety contact with PMDA and prefectural authorities, including preparation for inspections and responses to safety-related inquiries.

  • Design scalable local safety governance and operating models in preparation for future commercialization.

  • Ensuring that all GVP requirements are reflected in procedural documents supporting the pharmacovigilance system.

Required Skills, Experience and Education:

  • Bachelor, Master, or PhD or other equivalent advanced degree in a biological or medically related field is required, and MD is preferable.

  • At least 10 years or more experience in one or more of the following areas:

    • Pharmacovigilance or drug safety

    • Clinical development with responsibility for safety reporting (e.g., SAE/SUSAR, DSUR)

    • Medical Affairs with involvement in safety evaluation or risk communication

    • Safety-related regulatory affairs or post-marketing surveillance planning

  • At least 3 years’ experience in safety management activities or similar duties, with experience in negotiation with regulators.

  • Comprehensive knowledge of Japanese safety-related regulations (GVP/GPSP) is required; knowledge of worldwide regulations is desired.

  • Ability to communicate with Japanese health authorities in Japanese.

  • Strong strategic thinking, analytical, and problem-solving skills with good communication, presentation, and interpersonal skills.

  • Experience within a global and multicultural environment and willingness to travel occasionally internationally.

Preferred Skills:

  • Experience serving as Safety Management Manager (Anseki) or equivalent role.

  • Experience interacting with PMDA.

  • Experience in a pre-commercial or start-up pharmaceutical environment.

  • Business-level English, Native level Japanese.

  • Experience defining, building, and leading processes across a regional safety function to support cross-functional effectiveness and corporate partnership.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.


We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
 
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
 
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.


 

View job listing ↗

Get the Saturday tech briefing

New company profiles, funding moves, and who’s hiring across the market — every Saturday morning.

REVOLUTION Medicines headquarters

Redwood City, CA

Company size

700700 employees

Founded

2014

Total raised

$4,254,400,102

View company profile ↗

Funding rounds

  • Post Ipo Debt$500M
  • Post Ipo Equity$1.5B
  • Post Ipo Debt$250M
  • Post Ipo Equity$750M
  • Post Ipo Equity$323.6M
  • Post Ipo Equity$264.5M
  • Post Ipo Equity$260.9M
  • Post Ipo Equity$179.4M
  • IPOUndisclosed
  • Series C$100M
  • Series B$56M
  • Series A$25M
  • Series A$45M